Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03342742 · ClinicalTrials.gov registry record · NA
Daily Caloric Restriction and Intermittent Fasting in Overweight and Obese Adults With Autosomal Dominant Polycystic Kidney Disease
A NA study of Polycystic Kidney, Autosomal Dominant, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- NA
- Development phase
- 29
- Enrollment target
- 1
- Study location
NCT03342742: Completed NA study of Polycystic Kidney, Autosomal Dominant, sponsored by University of Colorado, Denver.
NCT03342742 is a NA study of Polycystic Kidney, Autosomal Dominant that has completed, run by University of Colorado, Denver. The registered enrollment target is 29 participants, below the 70-participant average among 4 other Polycystic Kidney, Autosomal Dominant trials with a reported enrollment target (59% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03342742, a NA study of Polycystic Kidney, Autosomal Dominant, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- NA
- Development phase
- 29 participants
- Enrollment target
- 1
- Study location
Study Summary
The proposed research will determine the feasibility of delivering two behavioral weight loss interventions for 1 year in adults with autosomal dominant polycystic kidney disease (ADPKD) who are overweight or obese. The study will also compare these two interventions in terms of safety, acceptability, and tolerability. Last, this pilot trial will provide initial insight into a) biological changes and b) changes in kidney growth with each of the two weight loss interventions.
Primary Outcome
Numbers of individuals pre-screened
Conditions Studied
Interventions
- BEHAVIORAL Weight Loss
Study Locations (1)
Colorado
- Kristen Nowak - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2018-06-04 |
| Est. Completion | 2020-10-13 |
| Phase | NA |
What the finished NCT03342742 record still lists
NCT03342742 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 29 participants, a relatively small participant target, below the 70-participant average among 4 other Polycystic Kidney, Autosomal Dominant trials with a reported enrollment target (59% lower).
The record links to 1 condition, with Polycystic Kidney, Autosomal Dominant appearing as the primary indexed condition, and to 1 intervention - of which Weight Loss is the first listed.
NCT03342742 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT03342742 about?
NCT03342742 is a clinical study titled "Daily Caloric Restriction and Intermittent Fasting in Overweight and Obese Adults With Autosomal Dominant Polycystic Kidney Disease". The proposed research will determine the feasibility of delivering two behavioral weight loss interventions for 1 year in adults with autosomal dominant polycystic kidney disease (ADPKD) who are overweight or obese. The study will also compare these two interventions in terms of safety, acceptabilit...
What is the current status of trial NCT03342742?
This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2018-06-04. Estimated completion is 2020-10-13.
What conditions does trial NCT03342742 study?
This clinical trial studies the following conditions: Polycystic Kidney, Autosomal Dominant.
What interventions are being tested in trial NCT03342742?
The interventions under investigation include: Weight Loss (BEHAVIORAL).
Who is sponsoring clinical trial NCT03342742?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03342742 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Polycystic Kidney, Autosomal Dominant
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Feasibility of Study of Empagliflozin in Patients With Autosomal Dominant Polycystic Kidney Disease
ACTIVE NOT RECRUITING · Phase 2
-
Metformin as a Novel Therapy for Autosomal Dominant Polycystic Kidney Disease
COMPLETED · Phase 2
-
Effect of Venglustat in Patients With Renal Impairment
COMPLETED · Phase 1
-
Effect of Statin Therapy on Disease Progression in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02429557 · 29 participants · Phase 1
Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure
- NCT02568878 · 29 participants · Phase 3
Creatine for Depressed Male and Female Methamphetamine Users
- NCT03014401 · 29 participants · NA
The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis
- NCT03128996 · 29 participants · Phase 1
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI